Anti-Human TNF Therapeutic Antibody (Infliximab)
Recombinant monoclonal antibody to Human TNF. Infliximab (INN; trade name Remicade) is a monoclonal antibody against tumour necrosis factor alpha (TNF-α) used to treat autoimmune diseases.
Infliximab was approved for the treatment of psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
Infliximab was approved for the treatment of psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-006 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | TNF |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in IF, IP, Neut, FuncS, ELISA, FC, WB and most other immunological methods. |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |